Choroid Plexus Neoplasms: Clinical Trials

86 trials for Choroid Plexus Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

54 completed, 16 terminated, 6 unknown, 5 withdrawn. 44 Phase 1, 13 Phase 2, 7 Not applicable, 7 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 144Completed 33, Terminated 7, Unknown 2, Recruiting 1, Withdrawn 1
Phase 213Completed 8, Terminated 2, Active not recruiting 1, Unknown 1, Withdrawn 1
Not applicable7Completed 2, Terminated 2, Withdrawn 2, Unknown 1
Phase 37Terminated 4, Completed 2, Unknown 1
Early Phase 11Completed 1

Follow Choroid Plexus Neoplasms: new trials by email Literature Review of Choroid Plexus Neoplasms trials Research Report on Choroid Plexus Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors
Pediatric Brain Tumors, Glioma
Not yet recruitingHuashan Hospital14002026-07-152026-07-23
Age Related Thresholds for Management of Severe Head Injury in Paediatrics: An Extension of STARSHIP
Traumatic Brain Injury, Pediatric
Enrolling by invitationCambridge University Hospitals NHS Foundation Trust4502026-03-012026-09-24
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
Observational - Glioma, Glioneuronal Tumor
RecruitingEuropean Organisation for Research and Treatment of Cancer - EORTC16502023-03-212025-12-17
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
ONC206 - Central Nervous System Neoplasms, Glioblastoma
Phase 1RecruitingJazz Pharmaceuticals1022020-10-262026-10-23
Rare CNS Tumors Outcomes &Risk
High Grade Meningioma, Ependymoma
CompletedNational Cancer Institute (NCI)3262017-08-212026-10-29
Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
Nivolumab, EKG, MRI Brain and/or spine - Medulloblastoma, Ependymoma
Phase 2TerminatedNational Cancer Institute (NCI)1362017-07-132026-10-27
Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
palbociclib isethionate, pharmacological study, laboratory biomarker analysis - Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma
Phase 1TerminatedPediatric Brain Tumor Consortium352014-12-082021-03-02
Molecular-Guided Therapy for Childhood Cancer
Guided Therapy - Neuroblastoma, Medulloblastoma
Not applicableCompletedGiselle Sholler1862014-07-082025-11-03
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
gallium Ga 68-edotreotide, positron emission tomography, computed tomography - Acoustic Schwannoma, Adult Anaplastic Astrocytoma
Not applicableWithdrawnSue O'Dorisio2013-09-012017-04-28
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
filgrastim - Childhood Choroid Plexus Tumor, Childhood Medulloblastoma
Phase 3TerminatedBarbara Ann Karmanos Cancer Institute232013-08-012020-10-29
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
azurin-derived cell-penetrating peptide p28 - Teratoid Tumor, Atypical, Choroid Plexus Neoplasms
Phase 1CompletedPediatric Brain Tumor Consortium182013-08-012017-08-07
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Gadobenate Dimeglumine, Gadobutrol - Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma
Not applicableTerminatedUniversity of Southern California142011-12-142017-03-27
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Real Acupressure Band, Placebo Acupressure Band - Central Nervous System Tumor, Pediatric, Chemotherapy-induced Nausea and Vomiting
Not applicableCompletedUniversity of South Florida1872011-05-012021-08-18
Yoga Therapy in Treating Patients With Malignant Brain Tumors
yoga therapy, questionnaire administration, quality-of-life assessment - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Not applicableTerminatedWake Forest University Health Sciences92010-12-012018-07-03
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
3-Dimensional Conformal Radiation Therapy, Gamma-Secretase Inhibitor RO4929097, Intensity-Modulated Radiation Therapy - Acoustic Schwannoma, Adult Anaplastic (Malignant) Meningioma
Phase 1CompletedNational Cancer Institute (NCI)222010-05-012015-09-29
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1TerminatedNational Cancer Institute (NCI)1292010-03-012014-11-05
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)272010-02-012013-05-03
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
Carboplatin, Cisplatin, Cyclophosphamide - Brain Cancer, Choroid Plexus Tumors
Phase 3TerminatedTufts Medical Center272009-11-012019-08-20
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
vorinostat, bortezomib, pharmacological study - Childhood Burkitt Lymphoma, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)202009-08-012013-07-02

Showing 20 of 86. Sign in to see all of them.

Narrower conditions

Astrocytoma (72)  ·  Medulloblastoma (69)  ·  Oligodendroglioma (61)  ·  Central Nervous System Neoplasms (52)  ·  Familial ependymoma (44)  ·  Optic Nerve Glioma (42)  ·  Meningioma (31)  ·  Ependymoma (29)  ·  Brain Neoplasms (27)  ·  Glioma (27)  ·  Pinealoma (27)  ·  Neuroectodermal Tumors, Primitive (26)  ·  Glioblastoma (24)  ·  Rhabdoid Tumor (23)

Broader conditions

Brain Diseases (86)  ·  Central Nervous System Diseases (86)  ·  Cerebral Ventricle Neoplasms (86)  ·  Neoplasms by Site (86)  ·  Nervous System Diseases (86)  ·  Nervous System Neoplasms (86)  ·  Neoplasms by Histologic Type (82)  ·  Neoplasms, Glandular and Epithelial (80)  ·  Neoplasms, Nerve Tissue (80)  ·  Neoplasms (79)  ·  Neuroectodermal Tumors (79)  ·  Neoplasms, Germ Cell and Embryonal (77)  ·  Neoplasms, Neuroepithelial (75)  ·  Brain Neoplasms (59)  ·  Glioma (52)

Interventions

Temozolomide (13)  ·  Carboplatin (12)  ·  Cyclophosphamide (9)  ·  Filgrastim (9)  ·  Etoposide (8)  ·  Vincristine (8)  ·  Cisplatin (7)  ·  Peripheral Blood Stem Cell Transplantation (7)  ·  Radiotherapy (6)  ·  Methotrexate (5)  ·  Magnetic Resonance Spectroscopy (4)  ·  Donepezil (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Irinotecan (3)  ·  O(6)-benzylguanine (3)

Sponsors

National Cancer Institute (NCI) (18)  ·  Pediatric Brain Tumor Consortium (12)  ·  Children's Oncology Group (7)  ·  National Institutes of Health Clinical Center (CC) (5)  ·  Wake Forest University Health Sciences (5)  ·  Children's Cancer and Leukaemia Group (3)  ·  City of Hope Medical Center (3)  ·  University of South Florida (3)  ·  Barbara Ann Karmanos Cancer Institute (2)  ·  Case Comprehensive Cancer Center (2)  ·  Duke University (2)  ·  St. Jude Children's Research Hospital (2)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Cancer Research UK (1)  ·  Children's Hospital Los Angeles (1)

Countries

United States (75)  ·  Canada (12)  ·  Australia (6)  ·  United Kingdom (6)  ·  Switzerland (5)  ·  New Zealand (4)  ·  Puerto Rico (4)  ·  Ireland (3)  ·  France (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Greece (1)

Top investigators

Elizabeth Fox, MD (3)  ·  Amar Gajjar, MD (2)  ·  Henry S. Friedman, MD (2)  ·  Jana Portnow, MD (2)  ·  Jonathan L. Finlay, MB, ChB (2)  ·  Mark W. Kieran, MD, PhD (2)  ·  Susan M. Blaney, MD (2)  ·  AeRang Kim, MD (1)  ·  Allen R. Chen, MD, PhD, MHS (1)  ·  Amar Gajjar (1)  ·  Anne-Marie Langevin, MD (1)  ·  Antonio Omuro (1)  ·  Barbara Jean Bambach, MD (1)  ·  Brad H. Pollock, PhD (1)  ·  Brian R. Rood, MD (1)

Results publications

PMID 11410496, PMID 11807556, PMID 16234526, PMID 16533779, PMID 16549835, PMID 16914576, PMID 17610262, PMID 17634493, PMID 17941066, PMID 18281544, PMID 18281546, PMID 18470481, PMID 18989154, PMID 19065567, PMID 19075272, PMID 19430790, PMID 19543851, PMID 20044751, PMID 20049936, PMID 20460632, PMID 21850464, PMID 22480131, PMID 23554030, PMID 27020837, PMID 29778738, PMID 33502920, PMID 33945291, PMID 35417530, PMID 37553297, PMID 38347552, PMID 39101481, PMID 40052556, PMID 40721826, PMID 9849694

NIH funding

U01CA081457 (9), U01CA097452 (5), P30CA033572 (3), U10CA081920 (3), P30CA022453 (2), U10CA081851 (2), U10CA098543 (2), N01CM62202 (1), P30CA008748 (1), P30CA012197 (1), P30CA014089 (1), P30CA016672 (1), P30CA043703 (1), P30CA086862 (1), R01CA154619 (1)